References
- American Society of Clinical Oncology. Update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based clinical practice guidelines. J Clin Oncol 1996; 14: 1957–1960
- Livingston R B, Ellis G K, Gralow J R. Dose-intensive vinorel-bine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancer. J Clin Oncol 1997; 15: 1395–1400
- Lokich J, Anderson N, Bern M. Paclitaxel, cisplatin, etoposide combination chemotherapy: a comparison of dose intensity in two multifractionated dose schemes. Eur J Cancer 1998; 34: 664–667
- Lokich J, Anderson N, Bern M. Phase I—II study of multi-fractionated combination chemotherapy for advanced non-small cell lung cancer; taxol, platinol, navelbine (TPN). Cancer 1999; 85: 499–503
- Lokich J. Multifractionated dosing for cancer chemotherapy: a novel schedule and a work in progress. Cancer Invest 1999; 17: 551–554